The global Companion Animal Medicine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Companion animal Medicines are administered to pet or companion animals in order to keep them healthy and safe from diseases and other health issues
This report aims to provide a comprehensive presentation of the global market for Companion Animal Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Medicine. This report contains market size and forecasts of Companion Animal Medicine in global, including the following market information:
- Global Companion Animal Medicine Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Companion Animal Medicine Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Companion Animal Medicine companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Companion Animal Medicine include Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH., Elanco Animal Health Incorporated, Virbac S.A., Biogenesis Bago SA, Piramal Group, Zoetis, NEOGEN Corporation. and Vetoquinol S.A., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Companion Animal Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Animal Medicine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Companion Animal Medicine Market Segment Percentages, by Type, 2023 (%)
- Vaccine
- Antibiotics
- Anti-inflammatory
- Others
Global Companion Animal Medicine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Companion Animal Medicine Market Segment Percentages, by Application, 2023 (%)
- Veterinary Clinics and Hospitals
- E-commerce
- Pharmaceutical Stores
- Others
Global Companion Animal Medicine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Companion Animal Medicine Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Companion Animal Medicine revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Companion Animal Medicine revenues share in global market, 2023 (%)
- Key companies Companion Animal Medicine sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Companion Animal Medicine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck Animal Health (Merck & Co., Inc.)
- Boehringer Ingelheim International GmbH.
- Elanco Animal Health Incorporated
- Virbac S.A.
- Biogenesis Bago SA
- Piramal Group
- Zoetis
- NEOGEN Corporation.
- Vetoquinol S.A.
- Ceva Sant Animale
Outline of Major Chapters:
Chapter 1: Introduces the definition of Companion Animal Medicine, market overview.
Chapter 2: Global Companion Animal Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Companion Animal Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Companion Animal Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Companion Animal Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
